title: Immunization with an anti-idiotypic antibody against the broadly lipopolysaccharide-reactive antibody WN1 222-5 induces Escherichia coli R3-core-type specific antibodies in rabbits.
abstract: The mouse monoclonal antibody (mAb) WN1 222-5 recognizes a carbohydrate epitope in the inner core region of LPS that is shared by all strains of Escherichia coli and Salmonella enterica and is able to neutralize their endotoxic activity in vitro and in vivo. Immunization of mice with mAb WN1 222-5 yielded several anti-idiotypic mAbs one of which (mAb S81-19) competitively inhibited binding of mAb WN1 222-5 to E. coli and Salmonella LPS. After immunization of rabbits with mAb S81-19, the serological responses towards LPS were characterized at intervals over two years. Whereas the serological response against the anti-idiotype developed as expected, the anti-anti-idiotypic response against LPS developed slowly and antibodies appeared after 200 d that bound to E. coli LPS of the R3 core-type and neutralized its TNF-α inducing capacity for human peripheral mononuclear cells. We describe the generation of a novel anti-idiotypic antibody that can induce LPS core-reactive antibodies upon immunization in rabbits and show that it is possible, in principle, to obtain LPS neutralizing antibodies by anti-idiotypic immunization against the mAb WN1 222-5. The mimicked epitope likely shares common determinants with the WN1 222-5 epitope, yet differences with respect to either affinity or specificity do exist, as binding to smaller oligosaccharides of the inner core was not observed.
authors.affiliation: Research Center Borstel, Leibniz-Center for Medicine and Biosciences, Borstel, Germany.
authors.forename: Lore
authors.initials: L
authors.lastname: Brade
authors.forename: Holger
authors.initials: H
authors.lastname: Heine
authors.forename: Satish
authors.initials: S
authors.lastname: Raina
authors.forename: Gracjana
authors.initials: G
authors.lastname: Klein
authors.forename: Franco
authors.initials: F
authors.lastname: Di Padova
authors.forename: Helmut
authors.initials: H
authors.lastname: Brade
authors.forename: Sven
authors.initials: S
authors.lastname: Müller-Loennies
mesh_terms: D000818:Animals; D000888:Antibodies, Anti-Idiotypic / Q000276:immunology*; D000907:Antibodies, Bacterial / Q000096:biosynthesis* / Q000276:immunology*; D055910:Antibodies, Immobilized / Q000276:immunology; D000911:Antibodies, Monoclonal / Q000096:biosynthesis* / Q000276:immunology*; D000937:Antigen-Antibody Reactions / Q000187:drug effects; D019921:Biotinylation; D015153:Blotting, Western; D002459:Cell Fusion; D004591:Electrophoresis, Polyacrylamide Gel; D004797:Enzyme-Linked Immunosorbent Assay; D004926:Escherichia coli / Q000276:immunology*; D006801:Humans; D006825:Hybridomas; D007114:Immunization; D007140:Immunoglobulin Fab Fragments / Q000276:immunology / Q000302:isolation & purification; D009000:Monocytes / Q000187:drug effects; D009844:Oligosaccharides / Q000276:immunology; D011817:Rabbits; D019779:Salmonella enterica / Q000276:immunology; D013268:Stimulation, Chemical; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology
chemical_list: D000888:Antibodies, Anti-Idiotypic; D000907:Antibodies, Bacterial; D055910:Antibodies, Immobilized; D000911:Antibodies, Monoclonal; D007140:Immunoglobulin Fab Fragments; D009844:Oligosaccharides; D014409:Tumor Necrosis Factor-alpha